Use Of Antihypertensive Drugs By Medicare Enrollees: Does Type Of Drug Coverage Matter?
Open Access
- 1 January 2001
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 20 (1) , 276-286
- https://doi.org/10.1377/hlthaff.20.1.276
Abstract
Research has demonstrated that Medicare beneficiaries with drug coverage consume more clinically essential drugs. However, generosity of coverage varies considerably across beneficiaries. This study examines the association between types of drug coverage and the consumption and cost per tablet of essential antihypertensive medications among beneficiaries with hypertension. The findings indicate that while both state- and employer-sponsored drug coverage are associated with greater consumption of antihypertensive drugs and lower out-of-pocket costs per tablet, private supplemental coverage is not associated with greater use and is associated with only slightly lower out-of-pocket costs than among noncovered beneficiaries.Keywords
This publication has 9 references indexed in Scilit:
- Insurance Coverage for Prescription DrugsMedical Care, 1999
- Estimating Causal Effects from Large Data Sets Using Propensity ScoresAnnals of Internal Medicine, 1997
- The Financial Burden of Prescription Drug Use Among Elderly PersonsThe Gerontologist, 1997
- Platelet membrane fluidity and platelet membrane lipid pattern in essential hypertensionAmerican Journal of Hypertension, 1995
- Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with SchizophreniaNew England Journal of Medicine, 1994
- Experience of State Drug Benefit ProgramsHealth Affairs, 1990
- Using Survey Data To Estimate Prescription Drug CostsHealth Affairs, 1990
- Smearing Estimate: A Nonparametric Retransformation MethodJournal of the American Statistical Association, 1983
- Effects of Treatment on Morbidity in HypertensionJAMA, 1967